News/July 22, 2026

Observational study finds microplastics present in 84% of serious heart attack patients — Evidence Review

Published in European Heart Journal, by researchers from Sant’Andrea Hospital, Sapienza University of Rome, Azienda Ospedaliera Universitaria Integrata of Verona, University of Campania Luigi Vanvitelli

Researched byConsensus— the AI search engine for science

Table of Contents

A new study found microplastics and nanoplastics in the coronary blood of 84% of patients who suffered a serious heart attack, suggesting a strong association between plastic particle exposure and cardiovascular disease. Related research broadly supports these findings, indicating that microplastics may contribute to cardiovascular risk through inflammation and vascular injury, though causality is not yet established; full study details are available from the original source.

  • Animal, in vitro, and human studies consistently report that micro- and nanoplastics can accumulate in cardiovascular tissues and may promote oxidative stress, inflammation, and plaque instability, all of which are implicated in heart attacks and other cardiovascular events 1 2 4 6 8 9.
  • Multiple studies have detected microplastics in human blood, atherosclerotic plaques, and other tissues, and their presence has been associated with increased risk of myocardial infarction, stroke, and all-cause mortality in prospective cohorts 1 7.
  • The new study identifies lifestyle (smoking) and environmental (air pollution) exposures as important factors influencing microplastic burden, a finding that complements earlier research on exposure routes and highlights the intersection of pollution, behavior, and cardiovascular health 1 2 10.

Study Overview and Key Findings

Concerns about microplastic pollution have expanded from environmental impacts to potential effects on human health, with recent studies implicating these particles in a range of illnesses. This new research is significant because it directly measures microplastic and nanoplastic particles in the coronary blood of patients at the time of heart attack, offering a rare window into potential links between environmental exposures and acute cardiovascular events. The study also explores how lifestyle and environmental factors, such as smoking and air pollution, relate to microplastic presence in the bloodstream—an area with limited prior data.

Property Value
Organization Sant’Andrea Hospital, Sapienza University of Rome, Azienda Ospedaliera Universitaria Integrata of Verona, University of Campania Luigi Vanvitelli
Journal Name European Heart Journal
Authors Dr. Pasquale Paolisso, Professor Emanuele Barbato, Professor Andreas Daiber
Population Patients with heart attack, chronic ischemic heart disease, or normal coron
Sample Size 61 patients
Methods Observational Study
Outcome Presence of microplastics in coronary blood, links to smoking and air pollution
Results Microplastics found in 84% of serious heart attack patients

To place this study in context, we searched the Consensus paper database, which includes over 200 million research papers. The following specific search queries were used:

  1. microplastics heart attack prevalence
  2. microplastics cardiovascular health effects
  3. serious heart attack patient risks

Below, we summarize key themes and findings from related studies:

Topic Key Findings
How do microplastics and nanoplastics affect cardiovascular health? - Micro- and nanoplastics can induce oxidative stress, inflammation, endothelial dysfunction, and promote atherosclerosis and plaque instability, mechanisms involved in cardiovascular disease 1 2 4 6 8 9 10.
- Animal and in vitro studies show exposure to polystyrene microplastics causes cardiac fibrosis, hypertrophy, and myocardial damage 6 8.
Are microplastics found in cardiovascular tissues and blood in humans? - Microplastics have been detected in human blood, atherosclerotic plaques, and cardiovascular tissues, with higher levels found in patients with cardiovascular disease or events 1 7 9.
- Their presence in carotid plaque is associated with a significantly increased risk of heart attack, stroke, or death 7.
What are the main routes and risk factors for microplastic exposure? - Inhalation, ingestion, and dermal contact are established exposure routes; smoking and air pollution increase microplastic burden in blood 2 10.
- Populations exposed to higher environmental microplastic pollution and individuals with cardiovascular risk factors may be more susceptible to adverse effects 4 10.
Is there evidence linking environmental microplastics to population-level cardiovascular risk? - Studies correlate higher environmental microplastic levels with increased prevalence of coronary artery disease, type 2 diabetes, and stroke at the population level 3.
- Epidemiological data support an association but not causation between microplastic exposure and cardiovascular risk, with further individual-level studies needed 3 4.

How do microplastics and nanoplastics affect cardiovascular health?

Multiple studies demonstrate that micro- and nanoplastics can affect cardiovascular health through mechanisms such as inflammation, oxidative stress, and endothelial dysfunction. These processes are known to contribute to atherosclerosis and acute cardiovascular events. The new study’s finding of higher microplastic levels in heart attack patients aligns with evidence from animal models and cellular studies.

  • Laboratory and preclinical models show that microplastics can induce oxidative stress, activate inflammatory pathways, and cause direct injury to the heart and blood vessels 1 6 8 9 10.
  • Microplastics promote processes associated with atherosclerosis, such as endothelial dysfunction, platelet aggregation, and cell senescence 1 2 4.
  • Animal studies reveal that polystyrene microplastics cause cardiac fibrosis and hypertrophy, and can promote cardiomyocyte apoptosis 6 8.
  • Reviews consistently identify microplastics as a potential novel environmental risk factor for cardiovascular disease, though more mechanistic and epidemiological research is needed 1 2 4 5 9 10.

Are microplastics found in cardiovascular tissues and blood in humans?

There is growing evidence that microplastics are present in human cardiovascular tissues, including atherosclerotic plaques and circulating blood. The detection of microplastics in the coronary blood of heart attack patients in the new study is consistent with multiple lines of research.

  • Microplastics and nanoplastics have been found in human blood, atherosclerotic plaques, myocardium, and other cardiovascular tissues 1 7 9.
  • A cohort study of patients undergoing carotid endarterectomy found that those with microplastics in their plaques had a fourfold higher risk of heart attack, stroke, or death during follow-up 7.
  • The presence of microplastics in cardiovascular tissues and plaques is associated with increased inflammatory markers and vascular injury 1 7.
  • Accumulation appears to be higher in areas of vascular lesions and may be linked to disease severity 1 7 9.

What are the main routes and risk factors for microplastic exposure?

Research identifies inhalation, ingestion, and dermal contact as primary exposure routes for micro- and nanoplastics, with certain behaviors and environmental conditions amplifying risk. The new study’s association between microplastic burden, smoking, and air pollution is consistent with prior findings.

  • Smoking is a significant risk factor, as it increases the likelihood of microplastics entering the bloodstream via the lungs 2 10.
  • Long-term exposure to air pollution (especially PM2.5) correlates with higher microplastic levels in blood and tissues 2 10.
  • Populations living in areas with higher environmental microplastic pollution, or those with pre-existing cardiovascular risk factors, may be at greater risk for adverse effects 4 10.
  • Ingestion via food and water, and inhalation of airborne microplastics, are the most studied exposure routes 2 10.

Is there evidence linking environmental microplastics to population-level cardiovascular risk?

While direct causation remains to be established, epidemiological studies suggest that communities exposed to higher levels of environmental microplastics have a greater prevalence of cardiovascular and metabolic diseases.

  • A cross-sectional study in US coastal counties found that very high marine microplastic levels were associated with increased prevalence of coronary artery disease, stroke, and diabetes, even after adjusting for confounders 3.
  • Literature reviews stress the need for longitudinal, individual-level studies to clarify the causal links and establish exposure thresholds for health impacts 3 4.
  • Population-level associations are strengthened by the mechanistic plausibility of microplastics promoting vascular injury and inflammation 1 2 4 5.
  • The new study adds individual-level evidence of higher microplastic burden in patients with acute cardiovascular events, helping bridge the gap between population and mechanistic research 1 3 7.

Future Research Questions

Despite mounting evidence, significant knowledge gaps remain regarding the health effects of micro- and nanoplastic exposure, especially concerning causality, exposure thresholds, and mechanisms in humans. Future research is needed to clarify the long-term clinical significance, identify vulnerable populations, and develop preventive strategies.

Research Question Relevance
Does reducing microplastic exposure lower the incidence of cardiovascular events? Understanding whether interventions targeting microplastic exposure translate into reduced cardiovascular risk is crucial for public health strategies and policy, as current evidence supports association but not causality 1 3 4.
What is the causal mechanism linking microplastics to heart attack risk? Elucidating the biological pathways by which microplastics might contribute to acute cardiovascular events will help clarify risk, enable targeted interventions, and address gaps highlighted by both experimental and observational studies 1 4 5 6.
Are certain types or sizes of microplastics more harmful to the cardiovascular system? Different polymers, sizes, and surface chemistries may have varying toxicities; identifying the most harmful forms could inform regulation and remediation priorities, as suggested by mechanistic studies 5 6 9 10.
How do genetic and lifestyle factors modify the effects of microplastic exposure? Interactions between microplastic exposure, genetics, and behaviors (such as smoking, diet, or pre-existing conditions) may explain differences in susceptibility and outcomes, requiring studies with diverse populations 2 4 14.
What are the long-term health effects of chronic microplastic exposure? Longitudinal data are needed to assess cumulative risk, latency periods, and chronic disease development, as current studies are largely cross-sectional or short-term 1 3 4 5.

Sources